In summary, the results show that the activation of the NLRP3/Caspase-1/IL-1β signaling pathway negatively regulates the hippocampal neuroinflammation and cognitive impairment induced by LPS (Figure 9). The gene discussed is NLRP3; the disease is Cognitive impairment.